Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cance

Published:2015-01-05 Issue:1 Volume:34 Page:41-49
ISSN:1000-467X
Container-title:Chinese Journal of Cancer
language:
Short-container-title:Chin J Cancer

Author:

Lopez-Guerrero Jose Antonio,Romero Ignacio,Poveda Andres

Publisher

Editorial Office of Chinese Journal of Cancer

Subject

Oncology

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Efficacy and Safety of Pazopanib Plus Chemotherapy in Treating Recurrent or Persistent Ovarian Cancer;American Journal of Clinical Oncology;2023-03-06

2. SRC-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathway;Medical Oncology;2023-01-10

3. Marine Derived Pharmaceuticals in Biomedical Research: Current Developments and Future Prospects;Marine Bioactive Molecules for Biomedical and Pharmacotherapeutic Applications;2023

4. CD133 as Biomarker and Therapeutic Target in Gynecologic Malignancies;Interdisciplinary Cancer Research;2023

5. Comparison of the Efficacy and Safety of PARP Inhibitors as a Monotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis;Frontiers in Oncology;2021-11-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP